- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00847951
Ultrasound for Perfusion in Neonates
September 18, 2017 updated by: Jonathan Rubin, M.D., University of Michigan
3D Ultrasound for Perfusion in Neonates
The purpose of this study is to evaluate the effectiveness of renal ultrasound to check kidney perfusion in premature and/or very low birth weight babies.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the effectiveness of 3D (3 dimensional)renal ultrasound to check kidney perfusion (to see if the kidney is receiving enough blood flow to function as it should) in premature and/or very low birth weight babies.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 4 weeks (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Very low birth weight babies in ICU in stable condition and/or premature babies in ICU in stable condition
Exclusion Criteria:
- Unstable very low birth weight/premature babies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Renal perfusion in Neonates
Ultrasound scanning with power Doppler is used to determine the fractional blood volume of the kidneys.
|
Ultrasound scanning with power Doppler is used to determine the fractional blood volume of the kidneys in pre-mature and/or very low birth weight babies.
This is a measure of perfusion and an indication of how well the kidneys are working.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine if ultrasound imaging can accurately help physicians determine if the kidneys are being adequately perfused.
Time Frame: 1 year
|
Fractional blood volume was determined as a way to measure kidney perfusion.
Adequate perfusion indicates that the kidneys are working and might indicate if a baby was responding to a specific treatment or not.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jonathan Rubin, MD, Univeristy of Michigan Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2008
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
February 17, 2009
First Submitted That Met QC Criteria
February 18, 2009
First Posted (Estimate)
February 19, 2009
Study Record Updates
Last Update Posted (Actual)
September 19, 2017
Last Update Submitted That Met QC Criteria
September 18, 2017
Last Verified
September 1, 2017
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Perfusion
-
Technical University of MunichUnknown
-
Universitätsklinikum Hamburg-EppendorfRecruitingTissue Perfusion | Microcirculation | Urethral Perfusion IndexGermany
-
University of NottinghamNot yet recruitingKidney Diseases | Ultrasonography | Kidney Injury, Acute | Perfusion ImagingUnited Kingdom
-
University of ZurichTerminatedCT Perfusion and MRI Perfusion in Solid TumorsSwitzerland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Not yet recruiting
-
Ain Shams UniversityNot yet recruiting
-
Shanglei LiuRecruitingPerfusion; ComplicationsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingPerfusion; ComplicationsChina
-
Assiut UniversityRecruiting
Clinical Trials on 3D Ultrasound Imaging
-
Pieter MuntendamIcahn School of Medicine at Mount Sinai; AstraZenecaEnrolling by invitationHeart Diseases | Stroke | Plaque, Atherosclerotic | Cardiovascular Risk Factor | Atherosclerotic DiseaseUnited States
-
Mayo ClinicTerminated
-
Sunnybrook Health Sciences CentreNot yet recruitingBreast Cancer | Breast MassesCanada
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | Mass Cystic | Benign MassUnited States
-
Sunnybrook Health Sciences CentreNot yet recruiting
-
The Geneva FoundationUniformed Services University of the Health Sciences; Brooke Army Medical CenterActive, not recruitingTraumatic Brain Injury | Intracranial Hemorrhages | Traumatic Brain Hemorrhage | Ultrasound Exams | 3D SONOGRAPHYUnited States
-
Mayo ClinicRecruitingOvarian Neoplasms | Ovarian Carcinoma | Adnexal Lesion | Female Reproductive System Neoplasm | Female Reproductive System Adnexal Neoplasm | Ovarian LesionUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
University of MichiganTerminatedTendon Injuries | Bone Injuries | Muscle InjuriesUnited States
-
British Columbia Cancer AgencyCompletedRadiation Therapy for Primary Breast CancerCanada